Amgen is a worldwide pioneer in biotechnology, harnessing the best of biology and technology to fight the world's toughest diseases. Founded in 1980 in Thousand Oaks, California, Amgen has grown from a pioneering biotech startup with just a handful of employees into one of the world's leading independent biotechnology companies. For over 45 years, Amgen has been committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. The company's reach extends to millions of patients globally, transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.
As an American multinational biopharmaceutical company, Amgen focuses on four key therapeutic areas: cardiovascular metabolic, bone health, inflammation, and oncology. The company's robust pipeline leverages state-of-the-art science and molecular engineering, pursuing transformative medicines with large effects. Amgen's commitment to patients is matched by its investment in its workforce, offering comprehensive benefits that support work-life balance, health, and career growth. With operations spanning the globe and a mission to make people's lives easier, fuller, and longer, Amgen continues to push the boundaries of what's possible in biotechnology and medicine.